The American Journal of Pathology published the first report of the presence of alternative lengthening of telomeres (ALT) that can be used as a diagnostic indicator and could be significant for developing anti-cancer therapies for cancers in the bladder, cervix, endometrium, esophagus, gallbladder, liver, and lung...
More...
More...